Drug News
Women More Often Treated with Low-Dose Dabigatran
Despite trend toward lower stroke risk with high dose
Your search for dabigatran returned 8 results
News
Stroke, Major Bleed Risk Compared Among Novel Oral Anticoagulants
The study analyzed data from NVAF patients newly initiating treatment with dabigatran, rivaroxaban or apixaban.
Drugs in the Pipeline
Pradaxa Under Review for DVT and PE
The FDA has accepted for review the sNDA for Pradaxa (dabigatran etexilate mesylate; Boehringer Ingelheim) in patients with deep vein thrombosis (DVT) and pulmonary embolism (PE).
News
Impact of Oral Anticoagulants on Renal Outcomes Compared
Compared with warfarin, dabigatran and rivaroxaban linked to lower risk of adverse renal outcomes
News
GI Bleed Hospitalization Risk Linked to Oral Anticoagulant Choice, PPI Cotherapy
To compare the incidence of hospitalization for upper GI tract bleeding, researchers used US Medicare beneficiary files to identify a cohort of patients that were ≥30 years old who initiated oral anticoagulation therapy with apixaban, dabigatran, rivaroxaban, or warfarin, with or without PPI cotherapy.
Safety Alerts and Recalls, Uncategorized
Single Lot of Pradaxa 75mg Recalled
Boehringer Ingelheim announced that it is conducting a nationwide recall of a single manufacturing lot of Pradaxa (dabigatran etexilate mesylate) capsules 75mg.
Drug News
AAN: Anticoagulation with Nonvalvular Atrial Fibrillation
Most people with nonvalvular atrial fibrillation (NVAF) should be taking oral anticoagulants to prevent stroke.
Clinical Charts
Thromboembolic Disorder Assessment: DVT/PE
Risk factors, prevention strategies, signs & symptoms, and general treatment options for deep vein thrombosis (DVT) and pulmonary embolism (PE).
